Your browser doesn't support javascript.
loading
Validation of the Passive Surveillance Stroke Severity Score in Three Canadian Provinces.
Yu, Amy Y X; Austin, Peter C; Park, Alison L; Fang, Jiming; Hill, Michael D; Kamal, Noreen; Field, Thalia S; Joundi, Raed A; Peterson, Sandra; Zhao, Yinshan; Kapral, Moira K.
Afiliación
  • Yu AYX; Department of Medicine (Neurology), University of Toronto, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Austin PC; ICES, Toronto, ON, Canada.
  • Park AL; ICES, Toronto, ON, Canada.
  • Fang J; ICES, Toronto, ON, Canada.
  • Hill MD; ICES, Toronto, ON, Canada.
  • Kamal N; Departments of Clinical Neurosciences, Community Health Sciences, Medicine, Radiology and Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
  • Field TS; Department of Industrial Engineering, Dalhousie University, Halifax, NS, Canada.
  • Joundi RA; Department of Medicine (Neurology), Vancouver Stroke Program, University of British Columbia, Vancouver, BC, Canada.
  • Peterson S; Department of Medicine, Hamilton Health Sciences Centre, McMaster University, Hamilton, ON, Canada.
  • Zhao Y; Centre for Health Services and Policy Research, University of British Columbia, Vancouver, BC, Canada.
  • Kapral MK; Population Data BC, University of British Columbia, Vancouver, BC, Canada.
Can J Neurol Sci ; : 1-6, 2024 Mar 06.
Article en En | MEDLINE | ID: mdl-38443764
ABSTRACT

BACKGROUND:

Stroke outcomes research requires risk-adjustment for stroke severity, but this measure is often unavailable. The Passive Surveillance Stroke SeVerity (PaSSV) score is an administrative data-based stroke severity measure that was developed in Ontario, Canada. We assessed the geographical and temporal external validity of PaSSV in British Columbia (BC), Nova Scotia (NS) and Ontario, Canada.

METHODS:

We used linked administrative data in each province to identify adult patients with ischemic stroke or intracerebral hemorrhage between 2014-2019 and calculated their PaSSV score. We used Cox proportional hazards models to evaluate the association between the PaSSV score and the hazard of death over 30 days and the cause-specific hazard of admission to long-term care over 365 days. We assessed the models' discriminative values using Uno's c-statistic, comparing models with versus without PaSSV.

RESULTS:

We included 86,142 patients (n = 18,387 in BC, n = 65,082 in Ontario, n = 2,673 in NS). The mean and median PaSSV were similar across provinces. A higher PaSSV score, representing lower stroke severity, was associated with a lower hazard of death (hazard ratio and 95% confidence intervals 0.70 [0.68, 0.71] in BC, 0.69 [0.68, 0.69] in Ontario, 0.72 [0.68, 0.75] in NS) and admission to long-term care (0.77 [0.76, 0.79] in BC, 0.84 [0.83, 0.85] in Ontario, 0.86 [0.79, 0.93] in NS). Including PaSSV in the multivariable models increased the c-statistics compared to models without this variable.

CONCLUSION:

PaSSV has geographical and temporal validity, making it useful for risk-adjustment in stroke outcomes research, including in multi-jurisdiction analyses.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Can J Neurol Sci Año: 2024 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Can J Neurol Sci Año: 2024 Tipo del documento: Article País de afiliación: Canadá